Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of M518101 ointment versus Daivonex and vehicle in plaque psoriasis
2013-001632-21Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pefcalcitol in plaque psoriasis (3 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Percent reduction in modified Psoriasis Area and Severity Index (mPASI) and Success rate based on Investigator's Global Assessment (IGA). Started Jul 2013; status: completed.
02
Drugs
pefcalcitol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2013-001632-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001632-21.